The DOI matches its Crossref record.
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- Black, 1990, Epidemiology of travelers' diarrhea and relative importance of various pathogens, Rev Infect Dis, 12, S73, 10.1093/clinids/12.Supplement_1.S73 · DOI · Paper page
- 1999, New frontiers in the development of vaccines against enterotoxigenic (ETEC) and enterohaemmorrhagic (EHEC) E coli infections, Wkly Epidemiol Rec, 74, 98
- Bouckenooghe, 2002, Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico, J Travel Med, 9, 137, 10.2310/7060.2002.23206 · doi:10.2310/7060.2002.23206
- Glenn, 2007, Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch, Expert Rev Vaccines, 6, 809, 10.1586/14760584.6.5.809 · DOI
- Glenn, 2007, Safety and immunogenicity of an ETEC vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum, Infect Immun, 75, 2163, 10.1128/IAI.01740-06 · DOI
- McKenzie, 2007, Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge study, Vaccine, 25, 3684, 10.1016/j.vaccine.2007.01.043 · DOI
- Freytag, 1999, Bacterial toxins as mucosal adjuvants, Curr Top Microbiol Immunol, 236, 215
- Steffen, 2005, Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea, J Travel Med, 12, 102, 10.2310/7060.2005.12207 · doi:10.2310/7060.2005.12207
- Qadri, 2005, Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups, Vaccine, 24, 1726, 10.1016/j.vaccine.2005.08.110 · doi:10.1016/j.vaccine.2005.08.110
- Sack, 2007, Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E coli diarrhoea of travellers to Guatemala and Mexico, Vaccine, 25, 4392, 10.1016/j.vaccine.2007.03.034 · doi:10.1016/j.vaccine.2007.03.034
- Steinsland, 2003, Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study, Lancet, 362, 286, 10.1016/S0140-6736(03)13971-2 · DOI
- Dupont, 1977, Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University, Am J Epidemiol, 105, 37, 10.1093/oxfordjournals.aje.a112353 · DOI
- Black, 1981, Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area, Bull World Health Organ, 59, 263
- Clemens, 1988, Cross-protection by B subunit-whole cell cholera vaccine against diarrhoea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial, J Infect Dis, 158, 372, 10.1093/infdis/158.2.372 · DOI
- Peltola, 1991, Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine, Lancet, 338, 1285, 10.1016/0140-6736(91)92590-X · DOI · Paper page
- Scerpella, 1995, Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea, J Travel Med, 2, 22, 10.1111/j.1708-8305.1995.tb00615.x · doi:10.1111/j.1708-8305.1995.tb00615.x
- Wiedermann, 2000, Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report), J Travel Med, 7, 27, 10.2310/7060.2000.00007 · doi:10.2310/7060.2000.00007
- Look, 2007, The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines, BioPharm International: guide to vaccine development and manufacture, 20, 34
- Jiang, 2002, Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay), J Infect Dis, 185, 497, 10.1086/338834 · DOI · Paper page
- Adachi, 2001, Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world, Clin Infect Dis, 32, 1706, 10.1086/320756 · DOI · Paper page
- Jiang, 2000, Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992–1997, J Infect Dis, 181, 779, 10.1086/315272 · DOI
- Taylor, 2006, A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea, Am J Trop Med Hyg, 74, 1060, 10.4269/ajtmh.2006.74.1060 · DOI
- Bourgeois AL, Halpertn J, Grahek S, et al Vaccination of travelers to Guatemala (GU) and Mexico (MX) with an oral killed vaccine (OKV) for enterotoxigenic E coli (ETEC): Impact of vaccine “take” on risk of ETEC disease and infection with enteric pathogens. 4th International Conference on Vaccines for Enteric Diseases (VED 2007). Lisbon, Portugal. April 25–27, 2007.
- Allen, 2006, Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strains, Infect Immun, 74, 869, 10.1128/IAI.74.2.869-875.2006 · DOI
- Berberov, 2004, Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins, Infect Immun, 72, 3914, 10.1128/IAI.72.7.3914-3924.2004 · doi:10.1128/iai.72.7.3914-3924.2004
- Zhang, 2006, Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunity, Infect Immun, 74, 3607, 10.1128/IAI.01836-05 · DOI
- Crane, 2006, Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli, Infect Immun, 74, 1505, 10.1128/IAI.74.3.1505-1515.2006 · DOI
Cited by
CONSORT 2010 statement: extension to randomised pilot and feasibility trials.
Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016) · BMJ · doi:10.1136/bmj.i5239 · Cited by 3,404
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
on behalf of the PAFS consensus group, Eldridge, S. M., Chan, C. L., Campbell, M. J., Bond, C. M., Hopewell, S., Thabane, L., & Lancaster, G. A. (2016) · Pilot and Feasibility Studies · doi:10.1186/s40814-016-0105-8 · Cited by 2,843
Recent Advances in Understanding Enteric Pathogenic Escherichia coli
Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., & Finlay, B. B. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-13 · Cited by 1,569
Global Etiology of Travelers’ Diarrhea: Systematic Review from 1973 to the Present
Shah, N., DuPont, H. L., & Ramsey, D. J. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.609 · Cited by 326
Self-citationLewis, D. J. M., Huo, Z., Barnett, S., Kromann, I., Giemza, R., Galiza, E., Woodrow, M., Thierry-Carstensen, B., Andersen, P., Novicki, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006999 · Cited by 305
Metadata
- Authors
- Frech, S. A., DuPont, H. L., Bourgeois, A. L., McKenzie, R., Belkind-Gerson, J., Figueroa, J. F., Okhuysen, P. C., Guerrero, N. H., Martinez-Sandoval, F. G., Meléndez-Romero, J. H., Jiang, Z.-D., Asturias, E. J., Halpern, J., Torres, O. R., Hoffman, A. S., Villar, C. P., Kassem, R. N., Flyer, D. C., Andersen, B. H., Kazempour, K., Breisch, S. A., & Glenn, G. M.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 371
- Issue
- 9629
- Pages
- 2019-2025
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2105433670
- Cited by
- 205
- References
- 0
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. https://app.cochat.ai/papers/10.1016/s0140-6736(08)60839-9
- The paper
- Frech, S. A., DuPont, H. L., Bourgeois, A. L., McKenzie, R., Belkind-Gerson, J., Figueroa, J. F., Okhuysen, P. C., Guerrero, N. H., Martinez-Sandoval, F. G., Meléndez-Romero, J. H., Jiang, Z.-D., Asturias, E. J., Halpern, J., Torres, O. R., Hoffman, A. S., Villar, C. P., Kassem, R. N., Flyer, D. C., Andersen, B. H., . . . Glenn, G. M. (2008). Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. The Lancet. https://doi.org/10.1016/s0140-6736(08)60839-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.